Skip to main content
Top Button

Life Sciences

The life sciences and biotechnology industries are working to improve human health and quality of life and also making significant advances in animal and plant life sciences. Companies in these industries are faced with a multitude of complex legal issues.

Ice Miller offers a multidisciplinary practice that helps clients deal with these complexities in creative ways and find solutions. Whether it is developing a portfolio of intellectual property assets, or raising capital for research and development, commercialization of ideas, later stage growth or ultimately a public offering or sale transaction, our team approach is valuable for a company that wants to take its ideas and concepts and turn them into products and services that improve people's lives. We are committed to the success of our clients and staying abreast of new legal and scientific developments to help in this success.
Our experience includes working with life science start-ups to help them with seed-stage funding. We have extensive experience with all types of funds (formations and operations); licensings; financings; leveraged buyouts, roll-ups, build-ups, and consolidations; divestitures and exits; and complex litigation on behalf of investors and privately financed companies.
Our experience helps life sciences companies find solutions through legislation and effective regulatory and governmental affairs. Our extensive product liability experience for several Fortune 500 pharmaceutical and medical device companies provides invaluable "lessons learned" to help all clients, startup to multinational, attempt to avoid the problems which lead to litigation or be best positioned should it occur.
And because of our experience, existing clients seek our assistance with cutting edge issues facing the life sciences industry with the advance of genomics, data exchanges, personalized medicine and corresponding privacy and bioethical issues, to name a few.
Our experience, found in over 50 life sciences lawyers and professionals, can help you turn your ideas into success stories.
For your industry, it's more than life science. It's lifeblood.

Representative Experience

Outside General Counsel and Regulatory Support:
  • Provides outside general counsel services with day-to-day legal support to several life sciences companies including:
    • a global medical device company (assisted with 4 add-on acquisitions) which was selected as one of the fastest growing Midwest life science companies by a local business journal;
    • a dental service organization, providing management and support services to pediatric dentists;
    • a company specializing in imaging services for Phase 1-4 trials around the world;
    • a contract research organization and research site focused on improving the scientific accuracy of analgesic programs;
    • an organization providing industry-leading regulatory and quality consulting for medical device and pharmaceutical companies;
    • an oncology research entity that was acquired by a global pharmaceutical corporation; which wanted to provide its subsidiary outside general counsel support;
    • a biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections
    • a gene therapy biotechnology company with multiple therapeutics in the clinic and one on the market; and
    • a gene therapy biotechnology company focused on Parkinson's disease and other neurological conditions.
  • Provides ongoing regulatory support to global medical device and pharmaceutical companies by, among other things, reviewing advertising materials, counseling on product launches, assisting develop policies and procedures; and providing compliance training.
  • Has counseled a global pharmaceutical company regarding several clinical trial collaborations related to oncology, biologic and immunology therapies.
Transaction Counsel:
  • Represented sellers in a transaction involving the sale of its parenteral contract manufacturer subsidiary ($950MM);
  • Assisted a biopharmaceutical company on 10+ transactions including licensing, equity investments and acquisitions.
  • Seller’s counsel in a transaction involving the sale of the client’s largest independent clinical research site services company which focused on special populations and is a leader in central nervous system studies;
  • Transaction counsel for an early-stage biotechnology company developing therapies for rare neuromuscular and central nervous system diseases ($700MM);
  • Represented a diagnostics company with its sale to a national scientific instrumentation, company ($295MM)
  • Represented an Asian-based pharmaceutical company in a licensing transaction with a European-based pharmaceutical company;
  • Represented a global medical device company in multiple acquisitions including the acquisition of an entity that provides design and planning services and manufactures surgical guides and a corporation which manufactures a bone fixation system for treating multiple fractures;
  • Buyer’s counsel for several venture capital funds which focus on life science sector acquisitions including the acquisition and sale of:
    • ambulatory surgery center management companies;
    • clinical trial research companies; and
    • digital health software and hardware development companies.
  • Represented a global medical device company in several product line “carve-out” asset sales.
  • Represented a therapeutics company in connection with an asset purchase and licensing agreement with a company that develops therapies to treat inflammatory diseases and their related complications.
  • Represent a transgenic mouse company on numerous licensing and collaboration transactions.
  • Represented a biopharmaceutical company in numerous transactions including licensing, collaborations, equity investments, and acquisitions to facilitate their global expansion and expansion of their therapeutic portfolio.
  • Represented a biotechnology company in its licensing and Series Seed financing to support its development of biologic therapies to counter persistent infections associated with antibiotic resistance.
  • Legal counsel to a technology company in the negotiation and execution of a Distribution Agreement with a Chinese distributor for certain medical devices for the interventional cardiology market.
  • Counseled multiple medical device and biotechnology companies on a variety of legal and business matters including structuring, negotiating and preparing documentation for various rounds of financings, development of form agreements for employees and consultants, customers, suppliers, integration partners, and license agreements with strategic partners.
  • Represented a fund in its $40MM Series A round in a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases.
  • Represented a company in connection with Series A and B round investments in a clinical-stage company, which develops novel therapeutics in oncology and other diseases.
  • Represented a biotechnology company in its $50MM Series A round.
  • Represented a digital pathology start-up on multiple venture capital financing rounds and its eventual sale to a global diagnostics company.
  • Represented lead investor in $5MM Series Seed financing for pre-clinical drug development company.
  • Represented health care IT company in its $25MM Series C financing.
  • Represented health care IT company in its $50MM Series E Financing.
  • Legal counsel to a lead investor on secured and unsecured debt financing provided to a technology company in excess of $35MM.


Name Position Phone Email
Adam Arceneaux Office Managing Partner 317-236-2137
Holiday W. Banta Partner 317-236-5882
Joshua L. Christie Partner 317-236-5802
Troy J. Cole Partner 317-236-2173
Aaron J. Dixon Partner 317-236-2206
Dustin S. DuBois Partner 317-236-2251
Tami A. Earnhart Partner 317-236-2235
Stephen J. Hackman Partner 317-236-2289
Weihong Hsing, Ph.D. Office Managing Partner 215-446-8119
Josef Keglewitsch Partner 614-462-2279
TaeSoo Sean Kim Partner 212-824-4962
Fabian Koenigbauer Partner 202-807-4055
T. Earl LeVere Partner 614-462-1095
Drew J. Miroff Partner 317-236-2267
Ryan McCabe Poor Partner 317-236-5976
Kathleen Sheil Scheidt Partner 312-726-2541
Christopher S. Sears Partner 317-236-5891
Myra C. Selby Partner 317-236-5903
Dale Stackhouse Partner 317-236-2401
Taryn E. Stone Partner 317-236-5872
John R. Thornburgh Partner 317-236-2405
Richard J. Thrapp Partner 317-236-2442
Michael L. Tooley Partner 317-236-2118
Thomas A. Walsh Partner 317-236-5946
Sherry A. Fabina-Abney Senior Counsel 317-236-2446
Roger A. Gilcrest Senior Counsel 614-462-1055
Sheldon Heber, Ph.D. Senior Counsel 215-982-5157
Jesús Joanós i Timoneda, Ph.D. Senior Counsel 215-446-8138
Olga Voinarevich Of Counsel 317-221-2817
Philip A. Whistler Senior Counsel 317-236-2349
Kevin C. Woodhouse Senior Counsel 317-236-2154
Ming He, Ph.D. Associate 215-446-8127
Erik Olson Associate 614-462-1028
Simone Park Associate 212-835-6302
Marita Clarke Practice Group Director 317-236-5847
Virginia Hargest, Ph.D. Technical Advisor 215-446-8125
Andrew Baraniak, Ph.D. Patent Agent 215-446-8121
Megan Coyle, Ph.D. Patent Agent 215-446-8136
Michael Graham Patent Agent 202-807-4036
View Full Site View Mobile Optimized